Today: 3 February 2026
Subscribe
Browse Category

Financial Outlook News 4 December 2025 - 5 December 2025

CoreWeave (CRWV) Stock Today – Fresh News, Analyst Targets and 2026–2030 Outlook (December 5, 2025)

CoreWeave (CRWV) Stock Today – Fresh News, Analyst Targets and 2026–2030 Outlook (December 5, 2025)

CoreWeave, Inc. (Nasdaq: CRWV) has become one of the most closely watched AI infrastructure stocks of 2025. After a spectacular run to an all‑time high near $187 in June and a brutal 40–50% drawdown in the autumn, the Nvidia‑backed GPU cloud provider is again in the spotlight thanks to new financing, fresh analyst coverage and ongoing debate about its heavy…
5 December 2025
····
Sembcorp Industries (SGX: U96) Stock Today: India IPO Plans, Renewables Pipeline and 2026 Outlook (5 December 2025)

Sembcorp Industries (SGX: U96) Stock Today: India IPO Plans, Renewables Pipeline and 2026 Outlook (5 December 2025)

Sembcorp Industries Ltd (SGX: U96) has had a volatile few months, but as of the morning of 5 December 2025, its stock is still trading just under the S$6 mark, with a sizeable gap between the current share price and consensus analyst targets. At the same time, the group is pushing ahead with an India IPO, a string of renewables…
5 December 2025
····
TD Bank Q4 2025 Earnings: Dividend Hike, Deep Cost Cuts and AML Fallout Shape 2026 Outlook

TD Bank Q4 2025 Earnings: Dividend Hike, Deep Cost Cuts and AML Fallout Shape 2026 Outlook

Toronto-Dominion Bank (TD Bank Group, TSX: TD; NYSE: TD) ended 2025 with a paradox that’s becoming familiar to big-bank investors: lower reported profit, stronger underlying performance – and a higher dividend. On December 4, 2025, the bank reported fourth‑quarter results showing profit pressure from restructuring and regulatory cleanup costs, even as adjusted earnings topped analyst forecasts and capital markets and…
5 December 2025
···
Johnson & Johnson (JNJ) Stock on December 4, 2025: Price Action, Latest News, Analyst Targets and 2026 Outlook

Johnson & Johnson (JNJ) Stock on December 4, 2025: Price Action, Latest News, Analyst Targets and 2026 Outlook

Published: December 4, 2025 Johnson & Johnson (NYSE: JNJ) remains one of 2025’s standout defensive stocks. After a powerful run driven by stronger pharma growth, MedTech momentum and a string of acquisitions, the healthcare giant now trades close to record highs while still offering a solid dividend and relatively low volatility. At the same time, investors watching JNJ today must…
4 December 2025
···
Credo Technology Group (CRDO) Stock on 4 December 2025: Blowout AI Earnings, Rich Valuation and 2026 Outlook

Credo Technology Group (CRDO) Stock on 4 December 2025: Blowout AI Earnings, Rich Valuation and 2026 Outlook

Updated: December 4, 2025 – Not investment advice Credo Technology Group Holding Ltd (NASDAQ: CRDO) is one of the most talked‑about AI infrastructure stocks going into year‑end 2025. After a huge fiscal Q2 2026 earnings beat and aggressive guidance, the stock has rallied into the $180s and become a focal point for investors looking to play the build‑out of AI…
4 December 2025
····
Roku Stock (ROKU) on December 4, 2025: Guggenheim Upgrade, Insider Moves and 2026 Outlook

Roku Stock (ROKU) on December 4, 2025: Guggenheim Upgrade, Insider Moves and 2026 Outlook

Roku, Inc. (NASDAQ: ROKU) is heading into the crucial holiday quarter with its share price pulling back from recent highs, even as Wall Street raises price targets and fresh data confirms an improving profitability and connected‑TV (CTV) ad story. On Thursday, December 4, 2025, Guggenheim lifted its price target on Roku to $115 and reiterated a Buy rating, citing stronger‑than‑expected…
4 December 2025
····
Haleon PLC (HLN) Stock on December 4, 2025: Price, Latest News, Analyst Targets and 2026 Outlook

Haleon PLC (HLN) Stock on December 4, 2025: Price, Latest News, Analyst Targets and 2026 Outlook

Updated: December 4, 2025 Haleon PLC – the consumer‑health group behind Sensodyne, Voltaren, Advil, Panadol and Centrum – is ending 2025 in a strangely paradoxical place: the business is grinding out steady growth and strong cash flow, while the share price has been drifting lower in recent weeks. As of early trading on December 4, 2025, Haleon’s New York‑listed ADR…
4 December 2025
····
HSBC Bank Today: New Chair, AI Ambitions and Asia Pivot Shape the 2026 Outlook (4 December 2025)

HSBC Bank Today: New Chair, AI Ambitions and Asia Pivot Shape the 2026 Outlook (4 December 2025)

Key Takeaways 1. Who HSBC Is in December 2025 HSBC Holdings plc remains one of the world’s largest banking groups. As of 30 September 2025, the bank reported total assets of about US$3.23 trillion and serves customers in 57 countries and territories, with a particularly heavy tilt toward Asia despite its London headquarters.  HSBC Management’s formal guidance is that, excluding exceptional items, the…
4 December 2025
···
Rolls-Royce Holdings plc Stock on 4 December 2025: Share Price, Analyst Forecasts and 2026 Outlook

Rolls-Royce Holdings plc Stock on 4 December 2025: Share Price, Analyst Forecasts and 2026 Outlook

Rolls-Royce Holdings plc (LON: RR, OTC: RYCEY) goes into the final weeks of 2025 as one of the standout names on the FTSE 100, with the share price still close to record highs and debate intensifying over how much upside is left. As trading closed in London on 4 December 2025, Rolls-Royce shares were quoted at 1,067.5p (sell price) and…
4 December 2025
····
British American Tobacco (BTI) Stock Near 52‑Week High on 4 December 2025: Dividend Giant, Buybacks and 2026 Outlook

British American Tobacco (BTI) Stock Near 52‑Week High on 4 December 2025: Dividend Giant, Buybacks and 2026 Outlook

British American Tobacco p.l.c. (LSE: BATS, NYSE: BTI) heads into year‑end 2025 in a very different place from the deep‑value gloom of two years ago. The shares are trading close to 52‑week highs, the dividend stream has grown again, buybacks are shrinking the share count, and the company is leaning harder into “smokeless” products such as Vuse vapes, glo heated…
4 December 2025
····
HSBC Holdings Plc stock on 4 December 2025: new chair, AI push and stress‑test comfort reshape the outlook

HSBC Holdings Plc stock on 4 December 2025: new chair, AI push and stress‑test comfort reshape the outlook

HSBC Holdings Plc stock is trading close to multi‑year highs as investors digest a flurry of developments: a surprise appointment of a new group chair, a major generative‑AI partnership, solid stress‑test results from the Bank of England, and lingering legal costs from the Bernard Madoff case. Here’s what all of that means for HSBC’s share price, valuation and stock outlook…
4 December 2025
····
3i Group plc Stock Near 52‑Week Lows After Action Warning – Latest News, Analyst Forecasts and Outlook (4 December 2025)

3i Group plc Stock Near 52‑Week Lows After Action Warning – Latest News, Analyst Forecasts and Outlook (4 December 2025)

Updated: 4 December 2025 3i Group share price on 4 December 2025 3i Group plc (LON: III), the FTSE 100 private equity and infrastructure investor, remains under pressure in early December after a sharp sell‑off triggered by concerns over growth at its flagship investment, European discount retailer Action. In London trading on 4 December 2025, 3i shares were quoted around…
4 December 2025
····
1 … 7 8 9 10 11 12

Stock Market Today

  • Market Jitters on Lilly Earnings, Hopeful Signs for Housing Stocks
    February 3, 2026, 3:57 PM EST. Stocks dipped Tuesday as tech selloff pressured the S&P 500 and Nasdaq, with Nvidia down over 3%, despite CEO Jensen Huang dismissing rift rumors with OpenAI. Eli Lilly shares fell nearly 4% ahead of earnings, weighed by rival Novo Nordisk's poor 2026 sales and profit forecast amid U.S. price pressures and rising competition. Investors question if Lilly's volume growth from expanded patient access will offset declining drug prices. Meanwhile, housing stocks like Lennar and Taylor Morrison rallied on reports of a private investor-backed plan to increase entry-level home affordability, though the Trump administration has no active involvement, indicating early-stage talks. The market balances caution on pharma earnings with cautious optimism on housing initiatives.
Go toTop